Testing effectiveness (Phase 2)Ended earlyNCT01851174
What this trial is testing
Study to Evaluate Bi-weekly Dosing of Gemcitabine Plus Nab-Paclitaxel to Treat Metastatic Pancreatic Cancer
Who this might be right for
Pancreatic Carcinoma Non-resectableStage IV Pancreatic Cancer
Western Regional Medical Center 15